Literature DB >> 25470206

Is renal hyperfiltration protective in chronic kidney disease-stage 1 pregnancies? A step forward unravelling the mystery of the effect of stage 1 chronic kidney disease on pregnancy outcomes.

Giorgina Barbara Piccoli1, Rossella Attini, Federica Neve Vigotti, Silvia Parisi, Federica Fassio, Arianna Pagano, Marilisa Biolcati, Domenica Giuffrida, Alessandro Rolfo, Tullia Todros.   

Abstract

BACKGROUND: The correlation between advanced or proteinuric chronic kidney disease (CKD) and adverse pregnancy outcomes is intuitive, although how early CKD affects pregnancy remains unknown. Glomerular hyperfiltration is a physiological response to pregnancy, correlated with outcomes in hypertension or collagen diseases. The aim of the study was to correlate first trimester hyperfiltration with pregnancy outcomes in stage 1 CKD patients.
METHODS: A historical prospective study was conducted on the database of our Unit, gathering all pregnant CKD patients referred since 1 January 2000. From 383 pregnancies referred in 2000-2013, 75 patients were selected (stage 1 CKD, referred within the 14th gestational week, singleton deliveries, absence of diabetes, hypertension or nephrotic proteinuria at referral, body mass index [BMI] < 30); 267 'low-risk' pregnancies, followed in the same setting, served as controls. Glomerular filtration rate (GFR) was assessed by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and dichotomized at 120 mL/min. The odds for Caesarean section, prematurity, need for Neonatal Intensive Care Unit (NICU) were assessed by univariate analysis and logistic regression.
RESULTS: Risk for adverse pregnancy outcomes was not affected by hyperfiltration (univariate OR GFR ≥ 120 mL/min: Caesarean section 1.30 (0.46-3.65); preterm delivery: 0.84 (0.25-2.80)). In contrast, even in these cases with normal kidney function, stage 1 CKD was associated with prematurity (17.3% vs 4.9% P = 0.001), lower birth weight (3027 ± 586 versus 3268 ± 500 P < 0.001) need for NICU (12% vs 1.1% P < 0.001). In the multivariate analysis, the risks were significantly increased by proteinuria and maternal age but not by GFR.
CONCLUSIONS: In pregnant Stage 1 CKD patients, hyperfiltration was not associated with maternal-foetal outcomes, thus suggesting a need to focus attention on qualitative factors, eventually enhanced by age, as vascular stiffness, endothelial damage or oxidative stress.
© 2014 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  creatinine; creatinine clearance; pregnancy

Mesh:

Year:  2015        PMID: 25470206     DOI: 10.1111/nep.12372

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  10 in total

1.  Midterm eGFR and Adverse Pregnancy Outcomes: The Clinical Significance of Gestational Hyperfiltration.

Authors:  Sehoon Park; Seung Mi Lee; Joong Shin Park; Joon-Seok Hong; Ho Jun Chin; Ki Young Na; Dong Ki Kim; Kook-Hwan Oh; Kwon Wook Joo; Yon Su Kim; Hajeong Lee
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-13       Impact factor: 8.237

Review 2.  Hypertensive disorders in pregnancy.

Authors:  Casey Berry; Mohamed G Atta
Journal:  World J Nephrol       Date:  2016-09-06

3.  The GCKR Gene Polymorphism rs780094 is a Risk Factor for Gestational Diabetes in a Brazilian Population.

Authors:  Mauren Isfer Anghebem-Oliveira; Susan Webber; Dayane Alberton; Emanuel Maltempi de Souza; Giseli Klassen; Geraldo Picheth; Fabiane Gomes de Moraes Rego
Journal:  J Clin Lab Anal       Date:  2016-08-24       Impact factor: 2.352

4.  Association of Unilateral Renal Agenesis With Adverse Outcomes in Pregnancy: A Matched Cohort Study.

Authors:  Jessica Kendrick; John Holmen; Zhiying You; Gerard Smits; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2017-04-07       Impact factor: 8.860

Review 5.  Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question).

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Rossella Attini; Silvia Parisi; Federica Fassio; Valentina Loi; Martina Gerbino; Marilisa Biolcati; Antonello Pani; Tullia Todros
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

6.  Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience.

Authors:  Rossella Attini; Filomena Leone; Silvia Parisi; Federica Fassio; Irene Capizzi; Valentina Loi; Loredana Colla; Maura Rossetti; Martina Gerbino; Stefania Maxia; Maria Grazia Alemanno; Fosca Minelli; Ettore Piccoli; Elisabetta Versino; Marilisa Biolcati; Paolo Avagnina; Antonello Pani; Gianfranca Cabiddu; Tullia Todros; Giorgina B Piccoli
Journal:  BMC Nephrol       Date:  2016-09-20       Impact factor: 2.388

Review 7.  A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.

Authors:  Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Michele Giannattasio; Gina Gregorini; Franca Giacchino; Rossella Attini; Valentina Loi; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2016-03-17       Impact factor: 3.902

Review 8.  A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology.

Authors:  Gianfranca Cabiddu; Donatella Spotti; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Gina Gregorini; Franca Giacchino; Rossella Attini; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2018-06-14       Impact factor: 3.902

9.  The Association Between GFR Evaluated by Serum Cystatin C and Proteinuria During Pregnancy.

Authors:  Chatchai Kreepala; Atitaya Srila-On; Maethaphan Kitporntheranunt; Watcharapong Anakkamatee; Popthum Lawtongkum; Krittanont Wattanavaekin
Journal:  Kidney Int Rep       Date:  2019-04-08

10.  Pregnancy in a woman with recurrent immunoglobulin a nephropathy: A case report.

Authors:  A Carosso; M Zonca; L Colla; F Borella; L Daniele; C Benedetto
Journal:  Case Rep Womens Health       Date:  2018-08-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.